日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy of Underwater Endoscopic Mucosal Resection for Superficial Non-Ampullary Duodenal Epithelial Tumor

水下内镜黏膜切除术治疗浅表性非壶腹部十二指肠上皮肿瘤的疗效

期刊:Clinical Endoscopy
影响因子:2.3
doi:10.5946/ce.2020.147
Furukawa, Masanori; Mitoro, Akira; Ozutumi, Takahiro; Fujinaga, Yukihisa; Nakanishi, Keisuke; Kitagawa, Koh; Saikawa, Soichiro; Sato, Sinya; Sawada, Yasuhiko; Takaya, Hiroaki; Kaji, Kosuke; Kawaratani, Hideto; Namisaki, Tadashi; Moriya, Kei; Akahane, Takemi; Yamao, Junichi; Yoshiji, Hitoshi
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites

腹水症状量表-7是评估托伐普坦治疗肝硬化腹水患者疗效的有效工具。

期刊:Experimental and Therapeutic Medicine
影响因子:2.3
doi:10.3892/etm.2020.9462
Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Shimozato, Naotaka; Kaji, Kosuke; Takaya, Hiroaki; Fujinaga, Yukihisa; Sawada, Yasuhiko; Sato, Shinya; Saikawa, Soichiro; Kubo, Takuya; Akahane, Takemi; Fukui, Hiroshi; Yoshiji, Hitoshi
肝硬化
发表日期：2021
文献求助 收藏

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients

利福昔明通过降低血清中可溶性CD163和甘露糖受体的水平以及部分改变肝硬化患者的肠道菌群来缓解内毒素血症

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics9040145
Kaji, Kosuke; Saikawa, Soichiro; Takaya, Hiroaki; Fujinaga, Yukihisa; Furukawa, Masanori; Kitagawa, Koh; Ozutsumi, Takahiro; Kaya, Daisuke; Tsuji, Yuki; Sawada, Yasuhiko; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi
信号转导
CD163
微生物学
肠道菌群
肝硬化
CD16
发表日期：2020
文献求助 收藏

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B

比较血清纤维化生物标志物在诊断慢性乙型肝炎患者显著肝纤维化中的应用

期刊:Experimental and Therapeutic Medicine
影响因子:2.3
doi:10.3892/etm.2020.8798
Tsuji, Yuki; Namisaki, Tadashi; Kaji, Kosuke; Takaya, Hiroaki; Nakanishi, Keisuke; Sato, Shinya; Saikawa, Soichiro; Sawada, Yasuhiko; Kitagawa, Kou; Shimozato, Naotaka; Kawaratani, Hideto; Moriya, Kei; Noguchi, Ryuichi; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi
肝炎
发表日期：2020
文献求助 收藏

Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis

左旋肉碱对肝硬化患者健康相关生活质量的影响

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2020.1372
Sato, Shinya; Namisaki, Tadashi; Furukawa, Masanori; Saikawa, Soichiro; Kawaratani, Hideto; Kaji, Kosuke; Takaya, Hiroaki; Shimozato, Naotaka; Sawada, Yasuhiko; Kitagawa, Koh; Moriya, Kei; Akahane, Takemi; Mitoro, Akira; Hoki, Noriyuki; Ann, Tatsuichi; Yoshiji, Hitoshi
肝硬化
发表日期：2020
文献求助 收藏

Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease

促甲状腺激素是导致非酒精性脂肪肝的独立危险因素。

期刊:JGH Open
影响因子:1.5
doi:10.1002/jgh3.12264
Tahara, Kazuki; Akahane, Takemi; Namisaki, Tadashi; Moriya, Kei; Kawaratani, Hideto; Kaji, Kosuke; Takaya, Hiroaki; Sawada, Yasuhiko; Shimozato, Naotaka; Sato, Shinya; Saikawa, Soichiro; Nakanishi, Keisuke; Kubo, Takuya; Fujinaga, Yukihisa; Furukawa, Masanori; Kitagawa, Koh; Ozutsumi, Takahiro; Tsuji, Yuuki; Kaya, Daisuke; Ogawa, Hiroyuki; Takagi, Hirotetsu; Ishida, Koji; Mitoro, Akira; Yoshiji, Hitoshi
代谢
脂肪肝
免疫/内分泌
发表日期：2020
文献求助 收藏

Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection

左旋肉碱对丙型肝炎病毒感染患者利巴韦林诱导的溶血性贫血的疗效

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2018.0070
Sato, Shinya; Moriya, Kei; Furukawa, Masanori; Saikawa, Soichiro; Namisaki, Tadashi; Kitade, Mitsuteru; Kawaratani, Hideto; Kaji, Kosuke; Takaya, Hiroaki; Shimozato, Naotaka; Sawada, Yasuhiko; Seki, Kenichiro; Kitagawa, Koh; Akahane, Takemi; Mitoro, Akira; Okura, Yasushi; Yamao, Junichi; Yoshiji, Hitoshi
炎症/感染
代谢
微生物学
贫血
肝炎
发表日期：2019
文献求助 收藏

Late-Evening Snack with Branched-Chain Amino Acid-Enriched Nutrients Does Not Always Inhibit Overt Diabetes in Patients with Cirrhosis: A Pilot Study

一项初步研究表明，富含支链氨基酸的夜宵并非总能抑制肝硬化患者的显性糖尿病。

期刊:Nutrients
影响因子:5
doi:10.3390/nu11092140
Nakanishi, Keisuke; Namisaki, Tadashi; Mashitani, Tsuyoshi; Kaji, Kosuke; Ozaki, Kuniaki; Saikawa, Soichiro; Sato, Shinya; Inoue, Takashi; Sawada, Yasuhiko; Kitagawa, Kou; Takaya, Hiroaki; Shimozato, Naotaka; Kawaratani, Hideto; Moriya, Kei; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi
糖尿病
肝硬化
代谢
发表日期：2019
文献求助 收藏

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

血管性血友病因子是评估乙型和丙型肝炎患者肝纤维化和预测肝细胞癌发生的有用生物标志物。

期刊:United European Gastroenterology Journal
影响因子:6.7
doi:10.1177/2050640618779660
Takaya, Hiroaki; Kawaratani, Hideto; Tsuji, Yuki; Nakanishi, Keisuke; Saikawa, Soichiro; Sato, Shinya; Sawada, Yasuhiko; Kaji, Kosuke; Okura, Yasushi; Shimozato, Naotaka; Kitade, Mitsuteru; Akahane, Takemi; Moriya, Kei; Namisaki, Tadashi; Mitoro, Akira; Matsumoto, Masanori; Fukui, Hiroshi; Yoshiji, Hitoshi
细胞生物学
肿瘤
肝炎
肿瘤免疫
发表日期：2018
文献求助 收藏

Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection

无干扰素方案治疗基因1型丙型肝炎病毒感染患者的疗效和耐受性

期刊:Experimental and Therapeutic Medicine
影响因子:2.3
doi:10.3892/etm.2018.6481
Takeda, Kosuke; Noguchi, Ryuichi; Namisaki, Tadashi; Moriya, Kei; Akahane, Takemi; Kitade, Mitsuteru; Kawaratani, Hideto; Shimozato, Naotaka; Kaji, Kosuke; Takaya, Hiroaki; Sawada, Yasuhiko; Seki, Kenichiro; Fujinaga, Yukihisa; Tsuji, Yuki; Kubo, Takuya; Sato, Shinya; Saikawa, Soichiro; Nakanishi, Keisuke; Furukawa, Masanori; Kitagawa, Koh; Ozutsumi, Takahiro; Kaya, Daisuke; Mitoro, Akira; Mashitani, Tsuyoshi; Okura, Yasushi; Yamao, Junichi; Yoshiji, Hitoshi
炎症/感染
肝炎
微生物学
发表日期：2018
文献求助 收藏